DataSheet1_Bioinformatic and Mechanistic Analysis of the Palmerolide PKS-NRPS Biosynthetic Pathway From the Microbiome of an Antarctic Ascidian.pdf

• Main Authors: Nicole E. Avalon (11875586), Alison E. Murray (5347574), Hajnalka E. Daligault (11875589), Chien-Chi Lo (123129), Karen W. Davenport (11875592), Armand E. K. Dichosa (11875595), Patrick S. G. Chain (7428695), Bill J. Baker (489970)
• Format: Dataset
• Language: unknown
• Published: 2021
• Subjects: Biochemistry; Environmental Chemistry; Geochemistry; Organic Chemistry; Inorganic Chemistry; Nuclear Chemistry; Medical Biochemistry: Proteins and Peptides (incl. Medical Proteomics); Medical Biochemistry and Metabolomics not elsewhere classified; Food Chemistry and Molecular Gastronomy (excl. Wine); Analytical Biochemistry; Cell Neurochemistry; Enzymes; Electroanalytical Chemistry; Analytical Chemistry not elsewhere classified; Organic Green Chemistry; Physical Organic Chemistry; Catalysis and Mechanisms of Reactions; Environmental Chemistry (incl. Atmospheric Chemistry); marine natural products; macrolide; biosynthetic gene clusters; Antarctic microbiology; trans-AT type I polyketide synthase; secondary metabolites; Antarctic; The Antarctic; Antarc*
• Online Access: https://doi.org/10.3389/fchem.2021.802574.s001

Complex interactions exist between microbiomes and their hosts. Increasingly, defensive metabolites that have been attributed to host biosynthetic capability are now being recognized as products of host-associated microbes. These unique metabolites often have bioactivity targets in human disease and can be purposed as pharmaceuticals. Polyketides are a complex family of natural products that often serve as defensive metabolites for competitive or pro-survival purposes for the producing organism, while demonstrating bioactivity in human diseases as cholesterol lowering agents, anti-infectives, and anti-tumor agents. Marine invertebrates and microbes are a rich source of polyketides. Palmerolide A, a polyketide isolated from the Antarctic ascidian Synoicum adareanum, is a vacuolar-ATPase inhibitor with potent bioactivity against melanoma cell lines. The biosynthetic gene clusters (BGCs) responsible for production of secondary metabolites are encoded in the genomes of the producers as discrete genomic elements. A candidate palmerolide BGC was identified from a S. adareanum microbiome-metagenome based on a high degree of congruence with a chemical structure-based retrobiosynthetic prediction. Protein family homology analysis, conserved domain searches, active site and motif identification were used to identify and propose the function of the ∼75 kbp trans-acyltransferase (AT) polyketide synthase-non-ribosomal synthase (PKS-NRPS) domains responsible for the stepwise synthesis of palmerolide A. Though PKS systems often act in a predictable co-linear sequence, this BGC includes multiple trans-acting enzymatic domains, a non-canonical condensation termination domain, a bacterial luciferase-like monooxygenase (LLM), and is found in multiple copies within the metagenome-assembled genome (MAG). Detailed inspection of the five highly similar pal BGC copies suggests the potential for biosynthesis of other members of the palmerolide chemical family. This is the first delineation of a biosynthetic gene cluster from an Antarctic microbial species, recently proposed as Candidatus Synoicihabitans palmerolidicus. These findings have relevance for fundamental knowledge of PKS combinatorial biosynthesis and could enhance drug development efforts of palmerolide A through heterologous gene expression.